Tuesday, March 26, 2019
wellness India Expo
Home Tags Biosimilar

Tag: Biosimilar

2019 can be a game-changer for bioscience industry?

The second last year of this decade signals towards fast nearing end of the obsolete regulations, technologies and ideas. The next decade is surely going to offer a huge leap forward to the bioscience sector in India and globally...……………..

Pharma world to discuss industry issues, showcase innovations at 70th IPC

The 70th Indian Pharmaceutical Congress will be inaugurated by Vice-President, Mr Venkaiah Naidu and will be held from December 21 to 23 at Amity University. The Industry leaders will discuss issues on APIs; generic formulations; diagnostics and medical devices..........................

Indian biosimilar market to be worth $40 billion by 2030

As per a recent paper, there is an active engagement in Indian industry with about 70 approved biosimilars yet urgent need to expand markets and de-clog RoW market access to actualize potential for global leadership...………….

ICT-Mumbai hosts 5 day workshop on biosimilar characterization

The workshop organized by the Institute of Chemical Technology in partnership with Biotechnology Industry Research Assistance Council witnessed extensive five-day training program, involving brainstorming lectures by esteemed keynote speakers............

BioVoice eMag March 2017 Issue-10 Volume-1

BioVoice eMag March 2017 Issue-10 Volume-1: This edition of BioVoice in its detailed cover story highlights the gains and pains of the budget 2017. The...

USFDA accepts Mylan & Biocon’s proposed biosimilar Pegfilgrastim for review

The development marks the second successful biologics license application (BLA) for filing of the partnership in the United States of America...

US-FDA accepts Mylan & Biocon’s joint application on biosimilar Trastuzumab

While the Biologics License Application (BLA) for MYL-1401O has been accepted by the United States FDA, if approved, it has the potential to be the first biosimilar Trastuzumab in the US....

We must strive to be a leader in biotech drug discovery,...

Listing out his mantra for science and entrepreneurship, the Prime Minister, Mr Narendra Modi during in his inaugural address at the Nobel Prize Series at Ahmedabad, exhorted the scientists to work towards making India a biotech hub....

Mylan & Biocon announce first joint USFDA submission for biosimilar, Trastuzumab

Besides being an important milestone of Biocon and Mylan's joint global biosimilars program, the first biosimilar trastuzumab if approved by the top regulator.....

Biosimilar or not? Avastin’s copy version awaits court’s verdict

Roche and Hetero drugs have been entangled in a bitter legal battle over the biosimilar rights...